Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies
if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the
same subfield and year (this is the minimum needed to enter the top 1%, not the average
within it), or reaches the top citation threshold in at least one of its specific research
topics.
Prevalence of Age-related Maculopathy in Australia
1995888 citationsPaul Mitchell, Karin Attebo et al.Ophthalmologyprofile →
The Prevalence of Retinal Vein Occlusion: Pooled Data from Population Studies from the United States, Europe, Asia, and Australia
2009827 citationsNing Cheung, Jie Jin Wang et al.Ophthalmologyprofile →
The relationship between glaucoma and myopia
1999754 citationsPaul Mitchell et al.Ophthalmologyprofile →
Prevalence of Open-angle Glaucoma in Australia
1996732 citationsPaul Mitchell, Karin Attebo et al.Ophthalmologyprofile →
Visual Acuity and the Causes of Visual Loss in Australia
1996686 citationsKarin Attebo, Paul Mitchell et al.Ophthalmologyprofile →
Epidemiology and Disease Burden of Pathologic Myopia and Myopic Choroidal Neovascularization: An Evidence-Based Systematic Review
2013519 citationsTien Yin Wong, Paul Mitchell et al.profile →
Visual Impairment and Falls in Older Adults: The Blue Mountains Eye Study
1998507 citationsRobert G. Cumming, Paul Mitchell et al.Journal of the American Geriatrics Societyprofile →
Risk factors for incident age-related macular degeneration
2004467 citationsRonald Klein, Paul Mitchell et al.Ophthalmologyprofile →
Peers — A (Enhanced Table)
Peers by citation overlap · career bar shows stage (early→late)
cites ·
hero ref
This map shows the geographic impact of Paul Mitchell's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Paul Mitchell with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Paul Mitchell more than expected).
This network shows the impact of papers produced by Paul Mitchell. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Paul Mitchell. The network helps show where Paul Mitchell may publish in the future.
Co-authorship network of co-authors of Paul Mitchell
This figure shows the co-authorship network connecting the top 25 collaborators of Paul Mitchell.
A scholar is included among the top collaborators of Paul Mitchell based on the total number of
citations received by their joint publications. Widths of edges
represent the number of papers authors have co-authored together.
Node borders
signify the number of papers an author published with Paul Mitchell. Paul Mitchell is excluded from
the visualization to improve readability, since they are connected to all nodes in the network.
Mitchell, Paul, Eric H. Souied, Edoardo Midena, et al.. (2019). Efficacy of Intravitreal Aflibercept Administered using Treat-and-Extend Regimen over 2 Years in Patients with Neovascular Age-Related Macular Degeneration: 1-Year ARIES Results.. Investigative Ophthalmology & Visual Science. 60(9). 117–117.2 indexed citations
Lee, Won Ki, Yuichiro Ogura, Tomohiro Iida, et al.. (2017). Efficacy and Safety of Intravitreal Aflibercept in Polypoidal Choroidal Vasculopathy: 12-Month Results of the PLANET Study. Investigative Ophthalmology & Visual Science. 58(8). 1199–1199.3 indexed citations
Rose, Kathryn, Amanda French, Paul Mitchell, & Ian G. Morgan. (2013). The role of time outdoors on the progression of refractive error in Australian children. Investigative Ophthalmology & Visual Science. 54(15). 5959–5959.1 indexed citations
11.
Buitendijk, Gabriëlle H.S., Elena Rochtchina, Chelsea E. Myers, et al.. (2013). Increasing the fidelity of AMD prediction models using population data from three continents. Investigative Ophthalmology & Visual Science. 54(15). 224–224.1 indexed citations
Bandello, Francesco, Frank G. Holz, Mark C. Gillies, Adrian Koh, & Paul Mitchell. (2012). Safety, Efficacy, And Treatment Patterns Of Ranibizumab Therapy For Neovascular Age-Related Macular Degeneration: The LUMINOUS Studies. Investigative Ophthalmology & Visual Science. 53(14). 2031–2031.2 indexed citations
14.
Tan, Gavin Siew Wei, Yingfeng Zheng, Wanling Wong, et al.. (2012). Prevalence, Causes and Risk Factors for Visual Impairment in a Multi-ethnic Asian Population with Diabetes. Investigative Ophthalmology & Visual Science. 53(14). 6344–6344.1 indexed citations
Flood, Victoria, et al.. (2008). Assembling a nutrient database for a large cohort study: the Blue Mountains Eye Study. Research Online (University of Wollongong). 60. 37–40.10 indexed citations
Mitchell, Paul, et al.. (1999). Impact of visual impairment on use of community support services by elderly persons: the Blue Mountains Eye Study.. PubMed. 40(1). 12–9.131 indexed citations
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive
bibliographic database. While OpenAlex provides broad and valuable coverage of the global
research landscape, it—like all bibliographic datasets—has inherent limitations. These include
incomplete records, variations in author disambiguation, differences in journal indexing, and
delays in data updates. As a result, some metrics and network relationships displayed in
Rankless may not fully capture the entirety of a scholar's output or impact.